Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Benign Tumor|Breast Malignant Tumor
Interventions: DRUG: Standard of Care (SOC) gadolinium Breast MRI|DRUG: reduced 1/4 dose gadolinium Breast MRI with Artificial Intelligence (AI) to aid in evaluation.
Sponsor: University of Alabama at Birmingham
Collaborators: Bracco Corporate